[Federal Register: August 3, 2005 (Volume 70, Number 148)]
[Notices]
[Page 44650-44656]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03au05-157]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
President's Malaria Initiative
Announcement Type: New.
Funding Opportunity Number: AA197.
Catalog of Federal Domestic Assistance Number: 93.283.
Key Dates: Application Deadline: September 2, 2005.
I. Funding Opportunity Description
Authority: This program is authorized under sections 307 and
317(k)(2) of the Public Health Service Act, [42 U.S.C. sections 242l
and 247b(k)(2)], as amended.
Purpose: The purpose of the program is to support malaria
prevention and control and relevant ancillary activities (e.g.,
baseline evaluation, strategy development, training, monitoring and
program evaluation) in the countries included in President Bush's
initiative to fight malaria in Africa.
On June 30, 2005, the President pledged to increase U.S. Government
funding of malaria prevention and treatment by more than $1 billion
over five years. The President made this commitment through the G-8
process as the U.S. contribution to a larger international effort
needed to reduce malaria deaths, and called on other donors,
foundations, private, public, and voluntary organizations to match U.S.
commitments by providing $1.2 billion annually in additional funding by
2008.
The President's commitment will more than triple the current U.S.
funding of malaria prevention and treatment programs in Africa, and is
in addition to the $200 million each year the United States spends
today on malaria prevention, treatment, and research. It will increase
U.S. funding for malaria to more than $500 million annually. The
current U.S. Government malaria budget for Fiscal Year (FY) 2005 is
$213.6 million, and of that amount the operating budget of the U.S.
Department of Health and Human Services (HHS) provides $102.4 million,
or nearly half of that amount. The U.S. Government is also currently
supporting malaria control and prevention through the Global Fund to
Fight AIDS, Tuberculosis and Malaria, which has so far been the largest
vehicle for U.S. Government assistance to anti-malaria activities; the
Global Fund has invested over $1 billion in malaria and prevention
control activities over two years, roughly one-third underwritten by
the U.S. contribution to the Global Fund. These additional resources
will complement those of the Global Fund and the World Bank's malaria
program.
The President will launch the initiative first in three countries:
Angola, Tanzania and Uganda. (Uganda and Tanzania are also countries
under the President's Emergency Plan for AIDS Relief), and will add
public-private partnerships in Equatorial Guinea and Zambia in FY 2006.
Over the next several years, the initiative could expand, with other
partner involvement, to a maximum of 25
[[Page 44651]]
countries. An inter-agency group selected the first countries according
to an agreed set of criteria, including significant burden of malaria;
national policies and practices for malaria control consistent with
international guidelines; country capacity to achieve large-scale
impact; other donor involvement; U.S. Government on-ground presence;
performance in other malaria programs, including the Global Fund; and
demonstrated political will by national government leadership to mount
a comprehensive effort to control malaria.
The goal of the President's initiative is to accomplish the
following after three years of full implementation:
Reduce malaria deaths in each of the target countries by
50 percent;
Achieve 85 percent coverage of proven malaria prevention,
control and treatment interventions among high-risk groups,
particularly children and pregnant women;
Procure directly drugs and other commodities and provide
training and technical assistance needed to achieve these objectives.
Specific interventions will include the following:
Expanding access to long-lasting insecticide treated bed
nets and indoor household residual spraying with approved insecticides
to greatly reduce the transmission of malaria.
Providing effective treatment of malaria through the
prompt use of new artemisinin combination therapies, now
internationally accepted as the treatment of choice against malaria.
Provision of these drugs will be available through public- and private-
sector outlets in target countries and supported by information and
education campaigns to improve access and delivery of care.
Providing effective, internationally agreed priority
interventions for addressing malaria in pregnancy, such as preventive
treatment of pregnant women; more than 30 million African women who
live in malaria-endemic areas become pregnant each year and are at risk
for malaria infection, which contributes to low birth weight and deaths
among infants.
Please see http://www.whitehouse.gov/news/releases/2005/06/20050630-8.html
for more information on the President's announcement.
This program addresses the ``Healthy People 2010'' focus area of
Immunization and Infectious Diseases.
Measurable outcomes of the program will be in alignment with the
numerical goals of the President's Malaria Initiative and the following
performance goal for the National Center for Infectious Diseases (NCID)
within the Centers for Disease Control (CDC) and Prevention of the U.S.
Department of Health and Human Services (HHS): Protect Americans from
infectious diseases.
This announcement is only for non-research activities supported by
HHS/CDC as part of the President's malaria initiative. If an applicant
proposes research, HHS/CDC will not review the application. For the
definition of ``research,'' please see the HHS/CDC Web site at the
following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm.
Activities: Awardee activities for this program are as follows:
The applicants and their partner(s) in the malaria-endemic
countries must:
--Enhance local capacity for implementing methods that will reduce
malaria transmission and the morbidity and mortality from malaria
infection in Angola, Equatorial Guinea, Tanzania, Uganda, or Zambia.
Applicants, in collaboration with the national governments and non-
governmental partners, including faith-based organizations, must base
their activities on the assessments made U.S. Government interagency
teams in each of the targeted countries of the President's Malaria
Initiative (if available prior to the application due date), and plan
to implement, in collaboration with a partner organization in the host
country, the priority malaria prevention activities identified through
the U.S. Government analysis.
Priority program areas are listed below, and are examples
of activities that would be appropriate to propose under this
announcement. The applicant should not duplicate existing efforts.
Based on their competitive advantage and proven field experience,
applicants may propose to undertake activities in one or more of the
priority program areas in a defined population area that will
contribute to the accomplishment of the numerical Emergency Plan
targets outlined above. For each of these activities, the grantee will
give priority to evidence-based, yet culturally adapted, innovative
approaches. Details and example activities for each appear in the
attachments, as posted with this announcement on the HHS/CDC Grants and
Cooperative Agreements Web site page:
Public health capacity-building for governments or
institutions so as to contribute to malaria prevention and control.
(Attachment 1, as posted with this announcement on the HHS/CDC Grants
and Cooperative Agreements Web site page).
--Increasing the public's access to effective antimalarial drugs and
appropriate management of malaria illness to reduce malaria-associated
mortality or the severity and duration of malaria illness. (Attachment
2, as posted with this announcement on the HHS/CDC Grants and
Cooperative Agreements Web site page).
--Reducing exposure to malaria, particularly among young children and
pregnant women, through the use of proven malaria-control
interventions, which should include the provision of long-lasting
insecticide-treated nets and indoor household residual insecticide
spraying. (Attachment 3, as posted with this announcement on the HHS/
CDC Grants and Cooperative Agreements Web site page).
--Preventing malaria and its adverse consequences during pregnancy.
(Attachment 4, as posted with this announcement on the HHS/CDC Grants
and Cooperative Agreements Web site page).
--Linking activities described here with related HIV care and other
social services, and promoting coordination at all levels, including
through bodies such as village, district, regional and national malaria
coordination committees and networks of faith-based organizations.
--Program evaluation, particularly assessment of progress against the
numerical goals of the President's Malaria Initiative. (Attachments 5
and 6, as posted with this announcement on the HHS/CDC Grants and
Cooperative Agreements Web site page).
Attend and participate in an annual meeting of grantee
representatives and the in-country management of the President's
Malaria Initiative to present, discuss, and evaluate program
activities.
Administration
The winning applicants must comply with all HHS management
requirements for meeting participation and progress and financial
reporting for this cooperative agreement. (See HHS Activities and
Reporting sections below for details.) The winning applicants must also
comply with all policy directives established by the interagency
Malaria Coordinator, housed at the U.S. Agency for International
Development.
In a cooperative agreement, HHS staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
[[Page 44652]]
HHS Activities for this program are as follows:
Organize an orientation meeting with the grantees to brief
them on applicable expectations, regulations and key management
requirements for the U.S. Government, HHS, and the President's Malaria
Initiative, as well as report formats and contents. The orientation
could include meetings with staff from HHS agencies and the staff of
the interagency Malaria Coordinator.
Review and approve the process used by the grantees to
select key personnel and/or post-award subcontractors and/or
subgrantees to be involved in the activities performed under this
agreement, as part of the annual review and approval of country plans
for the President's Malaria Initiative, managed by the interagency
Malaria Coordinator.
Provide consultation and assistance with training
curricula and materials, as necessary and appropriate for in-country
training programs.
Provide consultation and assistance on methods for
treatment of malaria, enhancing local capacity to increase use of
insecticide-treated bed nets and indoor household residual insecticide
spraying, and/or prevention of malaria and its adverse consequences
during pregnancy.
Provide consultation on program evaluation design.
Review and approve grantees' annual work plan and detailed
budget, as part of the annual review and approval of country plans for
the President's Malaria Initiative, managed by the interagency Malaria
Coordinator.
Review and approve grantees' monitoring and evaluation
plans, including for compliance with the strategic information guidance
established by the interagency Malaria Coordinator.
Meet on a monthly basis with grantees to assess monthly
expenditures in relation to approved work plan, and modify plans as
necessary.
Participate in an annual meeting of grantee
representatives to present, discuss, and evaluate program activities.
II. Award Information
Type of Award: Cooperative Agreement.
HHS involvement in this program appears in the Activities Section
above.
Fiscal Year Funds: 2005.
Approximate Current Fiscal Year Funding: $600,000.
Approximate Total Project Period Funding: $1,800,000 (This amount
is an estimate, and is subject to availability of funds. This includes
direct or indirect costs.).
Approximate Number of Awards: Four.
Approximate Average Award: $150,000 (This amount is for the first
12-month budget period, and includes both direct and indirect costs).
Floor of Individual Award Range: None.
Ceiling of Individual Award Range: $250,000 (This ceiling is for
the first 12-month budget period. This is for total costs, which would
include indirect costs.)
Anticipated Award Date: September 15, 2005.
Budget Period Length: 12 months.
Project Period Length: Three years.
Throughout the project period, HHS' commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government, through annual review and approval
of country plans for the President's Malaria Initiative, managed by the
interagency Malaria Coordinator.
III. Eligibility Information
III.1. Eligible applicants
Eligible applicants that can apply for this funding opportunity are
listed below:
Public, non-profit organizations
Private, non-profit organizations
Universities
Colleges
Research institutions
Hospitals
Community-based organizations
Faith-based organizations
Federally recognized Indian tribal governments
Indian tribal organizations
State and local governments or their Bona Fide Agents
(this includes the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, the Commonwealth of the Northern Marianna
Islands, American Samoa, Guam, the Federated States of Micronesia, the
Republic of the Marshall Islands, and the Republic of Palau)
Political subdivisions of States (in consultation with
States)
A Bona Fide Agent is an agency/organization identified by a State
as eligible to submit an application under the State eligibility in
lieu of a State application. If applying as a bona fide agent of a
State or local government, an applicant must provide a letter of
endorsement from the State or local government concerned as
documentation of its status as bona fide agent. Please place this
documentation behind the first page of the application form.
While both U.S.-based and organizations indigenous to Angola,
Equatorial Guinea, Tanzania, Uganda, or Zambia are eligible to apply,
we will give preference to well-established organizations indigenous to
those countries mentioned above, legally incorporated in those
countries, that have well-developed management and financial control
systems and established malaria activities that reach to rural areas of
those countries.
Preference will also go to applicants with demonstrated experience
in working with their identified indigenous country partner(s) on
malaria prevention and control activities.
III.2. Cost-Sharing or Matching
Matching funds are not required for this program. Although matching
funds are not required, preference will go to organizations that can
leverage additional funds to contribute to achieving the numerical
goals of the President's Malaria Initiative.
III.3. Other
If applicants request funding greater than the ceiling of the award
range, HHS/CDC will consider the application non-responsive, and it
will not enter into the review process. HHS/CDC will notify the
applicant that the application did not meet the submission
requirements.
Special Requirements: If the application is incomplete or non-
responsive to the requirements listed in this section, it will not
enter into the review process. We will notify the applicant that the
application did not meet submission requirements.
We will consider late applications non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
This program is not designed or intended to support
research, therefore this cooperative agreement will not support any
research.
Note: Title 2 of the United States Code section 1611
states that an organization described in section 501(c)(4) of the
Internal Revenue Code that engages in lobbying activities is not
eligible to receive Federal funds that constitute an award, grant, or
loan.
Applicants must show an established relationship with
indigenous partner organization(s) in the country/countries they
propose for their project by submitting a letter, on the partner's (or
partners') letterhead, of
[[Page 44653]]
support that shows an established relationship with indigenous partner
organization(s) in the country/countries the applicant proposes for the
project.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161-1.
Electronic Submission: HHS/CDC strongly encourages applicants to
submit the application electronically by using the forms and
instructions posted for this announcement on http://www.Grants.gov, the
official Federal agency-wide E-grant Web site. Only applicants who
apply on-line are permitted to forego paper copy submission of all
application forms.
Paper Submission: Application forms and instructions are available
on the HHS/CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If access to the Internet is not available, or if there is
difficulty accessing the forms on-line, contact the HHS/CDC Procurement
and Grants Office Technical Information Management Section (PGO-TIM)
staff at 770-488-2700, and we can mail the application forms to you.
IV.2. Content and Form of Submission
Application: Applicants must submit a project narrative the
application forms, in the following format:
Maximum number of pages: 25. If your narrative exceeds the
page limit, we will only review the pages that are within the page
limit.
Font size: 12-point, unreduced
Single-spaced
Paper size: 8.5 by 11 inches
Page margin size: One inch
All pages of the application numbered sequentially from
page 1 (Application Face Page) to the end of the application, including
charts, figures, tables, and appendices.
Printed only on one side of page
Held together only by rubber bands or metal clips; not
bound in any other way
The narrative should address activities the applicant proposes to
conduct over the entire project period, and must include the following
items in the order listed:
Background and Need
Objectives
Plan
Methods
Performance Methods
Timeline
Staff
Budget Justification (the budget justification will be
counted in the stated page limit)
Evidence that the applicant has notified the appropriate
agency in the government of the partner country/countries of the
application
Applicants must show an established relationship with
partner organization(s) in the country they propose for their project.
Applicants must include after the face page of the application a letter
with the indigenous partner's (partners') letterhead that provides a
brief description of the past and anticipated collaboration between the
applicant and the partner organization(s) in the host country/countries
must be included. Applicants must also include evidence (e.g. a letter)
that they have notified the appropriate agency or Ministry of Health
(MOH) in the partner country/countries of their intention to apply.
Applicants may include additional information included in the
application appendices. The appendices will not count toward the
narrative page limit. This additional information includes the
following:
Curricula Vitaes
R[eacute]sum[eacute]s
Organizational Charts
Letters of Support
Country Malaria Plan
The agency or organization is required to have a Dun and Bradstreet
Data Universal Numbering System (DUNS) number to apply for a grant or
cooperative agreement from the Federal government. The DUNS number is a
nine-digit identification number, which uniquely identifies business
entities. Obtaining a DUNS number is easy and there is no charge. To
obtain a DUNS number, access http://www.dunandbradstreet.com or call 1-866-
705-5711.
For more information, see the HHS/CDC Web site at: http://www.cdc.gov/od/pgo/funding/grantmain.htm.
If the application form does
not have a DUNS number field, please write the DUNS number at the top
of the first page of the application, and/or include the DUNS number in
the application cover letter.
Additional requirements that might require submittal of additional
documentation with the application are found in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
Application Deadline Date: September 2, 2005.
Explanation of Deadlines: Applications must be received in the HHS/
CDC Procurement and Grants Office by 4 p.m. Eastern Time on the
deadline date.
Applicants may submit applications electronically at
http://www.grants.gov. Applications completed on-line through Grants.gov are
considered formally submitted when the applicant organization's
Authorizing Official electronically submits the application to http://www.grants.gov.
HHS/CDC will consider electronic applications as having
met the deadline if the applicant organization's Authorizing Official
has submitted the application electronically to Grants.gov on or before
the deadline date and time.
If applicants submit material electronically through Grants.gov
(http://www.grants.gov), the application will be electronically time/
date stamped, which will serve as receipt of submission. Applicants
will receive an e-mail notice of receipt when HHS/CDC receives the
application.
If applicants submit material by the United States Postal Service
or commercial delivery service, the applicant must ensure the carrier
will be able to guarantee delivery of the application by the closing
date and time. If HHS/CDC receives the application after closing date
because of one of the following: (1) Carrier error, when the carrier
accepted the package with a guarantee for delivery by the closing date
and time, or (2) significant weather delays or natural disasters, the
applicant will have the opportunity to submit documentation of the
carrier's guarantee. If the documentation verifies a carrier problem,
HHS/CDC will consider the submission as having been received by the
deadline.
If applicants submit material in hard copy, HHS/CDC will not notify
the applicant upon receipt of the submission. If questions arise on the
receipt of the application, the applicant should first contact the
carrier. Applicants with further questions should please contact the
PGO-TIM staff at (770) 488-2700. The applicant should wait two to three
days after the submission deadline before calling. This will allow time
for HHS/CDC to process and log submissions.
This announcement is the definitive guide on application content,
submission address, and deadline. It supersedes information provided in
the application instructions. If the submission does not meet the
deadline above, it will not be eligible for review, and we will discard
it. We will notify the applicant if the application did not meet the
submission requirements.
[[Page 44654]]
IV.4. Intergovernmental Review of Applications
The application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for state and local governmental review of proposed Federal
assistance applications. Contact the state single point-of-contact
(SPOC) as early as possible to alert the SPOC to prospective
applications, and to receive instructions on the state's process. Visit
the following Web address to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html
.
IV.5. Funding Restrictions
Restrictions, which applicants must take into account while writing
their budgets, are as follows:
Funds may not support research.
Reimbursement of pre-award costs is not allowed.
Grantees may expend funds for reasonable program purposes,
including personnel, travel, supplies, and services. Grantees may
purchase equipment if deemed necessary to accomplish program
objectives; however, grantees must make any purchases through a
transparent and competitive process, after having requested and
received prior approval by HHS/CDC officials in writing.
The costs that are generally allowable in grants to
domestic organizations are allowable to foreign institutions and
international organizations, with the following exception: With the
exception of the American University, Beirut, the Gorgas Memorial
Institute, and the World Health Organization, indirect costs will not
be paid (either directly or through sub-award) to organizations located
outside the territorial limits of the United States or to international
organizations regardless of their location.
The applicant may contract with other organizations under
this program; however, the applicant must perform a substantial portion
of the activities (including program management and operations, and
delivery of prevention services for which funds are required.)
Applicants shall state all requests for funds contained in
the budget in U.S. dollars. After making an award, HHS/CDC will not
compensate foreign grantees for currency exchange fluctuations through
the issuance of supplemental awards.
You must obtain annual audit of these HHS/CDC funds
(program-specific audit) by a U.S.-based audit firm with international
branches and current licensure/authority in-country, and in accordance
with International Accounting Standards or equivalent standard(s)
approved in writing by HHS/CDC.
HHS/CDC can require a fiscal Recipient Capability
Assessment, prior to or post award, to review the applicant's business
management and fiscal capabilities regarding the handling of U.S.
Federal funds.
If requesting indirect costs in the budget, a copy of the indirect
cost rate agreement is required. If the indirect cost rate is a
provisional rate, the agreement should be less than 12 months old.
Applicants can find guidance for completing the budget on the HHS/
CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
Application Submission Address: Electronic Submission: HHS/CDC
strongly encourages applicants to submit applications electronically at
http://www.Grants.gov Applicants can download the application package from http://www.Grants.gov. Applicants are able to complete it off-
line, and then upload and submit the application via the Grants.gov Web
site. We will not accept e-mail submissions. Applicants that have
technical difficulties in Grants.gov can reach custumer service by E-
mail at http://www.grants.gov/CustomerSupport or by phone at 1-800-518-
4726 (1-800-518-GRANTS). The Customer Support Center is open from 7
a.m. to 9 p.m., Eastern Time, Monday through Friday.
HHS/CDC recommends that submittal of the application to Grants.gov
should be early to resolve any unanticipated difficulties prior to the
deadline. Applicants may also submit a back-up paper submission of the
application. We must receive any such paper submission in accordance
with the requirements for timely submission detailed in Section IV.3.
of the grant announcement. Applicants must clearly mark the paper
submission: ``BACK-UP FOR ELECTRONIC SUBMISSION.'' The paper submission
must conform to all requirements for non-electronic submissions. If
HHS/CDC receives both electronic and back-up paper submissions by the
deadline, we will consider the electronic version the official
submission.
We strongly recommend applicants submit the grant application by
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel,
etc.). If applicants do not have access to Microsoft Office products,
they may submit a PDF file. Applicants can find directions for creating
PDF files on the Grants.gov Web site. Use of file formats other than
Microsoft Office or PDF may make the file unreadable for our staff.
OR
Paper Submission: Applicants should submit the original and two
hard copies of the application by mail or express delivery service to:
Technical Information Management-RFAAA197, CDC Procurement and
Grants Office, U.S. Department of Health and Human Services, 2920
Brandywine Road, Atlanta, GA 30341.
V. Application Review Information
V.1. Criteria
Applicants must provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. Applicants must submit these measures of
effectiveness with the application, and they will be an element of
evaluation. HHS/CDC will evaluate the application against the following
criteria:
1. Plan of Operation (45 Points)
a. Do the key personnel have the ability and program skills to
develop and carry out the proposed activities, including by undertaking
those activities in the appropriate local languages?
b. Is there good evidence to show the applicant and malaria-endemic
partner(s) have conducted a collaborative review of the priority needs
for malaria in the malaria-endemic country/countries?
c. Do the proposed objectives match the priority issues and
interventions of the President's Malaria Initiative?
d. Are the proposed methods reasonable? Will they accomplish the
program goals? Is the proposed plan reasonable? Does it address major
project components in both the applicant and malaria-endemic country/
countries (i.e., leadership, staffing, administrative coordination,
planning, and measurement activities)? Does the timetable incorporate
the major numerical milestones of the President's Malaria Initiative
and have a coherent plan to meet those targets?
e. Is the plan consistent with malaria prevention best practices
and the
[[Page 44655]]
announced priorities of the President's Malaria Initiative?
f. If the applicant proposes capacity-building for public health
activities in malaria, do the planned activities relate to capacity
improvements that will help achieve the numerical goals of the
President's Malaria Initiative in the partner country/countries?
2. Collaborative Arrangement(s) (25 Points)
a. Does the collaboration between the applicant and partner
organization(s) in the partner country/countries reflect an effective
working relationship? Will the collaboration enable implementation of
the proposed activities and serve to achieve the numerical goals of the
President's Malaria Initiative?
b. Does the collaboration include the organization(s) responsible
for policy and implementation of malaria prevention and control in the
target area (e.g., Ministry of Health and/or district office)?
c. Are there formal letters of support from appropriate groups
(universities, non-governmental organizations, etc.) within the
malaria-endemic country that demonstrate the appropriate and necessary
cooperation to support malaria prevention and control programs?
3. Background and Need (15 Points)
a. Does the proposal define and provide evidence that malaria in
the partner malaria-endemic country/countries is well-established as an
important cause of morbidity and mortality across the country/
countries?
b. Is it clear what the existing malaria control program is and
what its prevention and control strategies are?
c. Does the application clearly describe the existing surveillance,
monitoring and evaluation methods and capability?
d. Does the application clearly describe the gaps and priorities in
malaria prevention and control implementation?
4. Evaluation Plan (15 Points)
a. Does the application include a reasonable detailed plan for
monitoring the implementation of the activities and evaluating the
extent to which the proposed activities strengthen local and national
capacity for malaria prevention and control?
b. Does the monitoring and evaluation plan build on existing
monitoring and evaluation systems in the project area? Will it be able
to demonstrate progress towards the objectives and numerical targets of
the President's Malaria Initiative?
5. Budget (Not Scored)
Is the budget detailed, clear, justified, and does it describe in-
kind or other project support? Is it consistent with the proposed
program activities and the President's Malaria Initiative?
V.2. Review and Selection Process
The Procurement and Grants Office (PGO) will review applications
for completeness, staff, and HHS/CDC/NCID will review them for
responsiveness. Incomplete applications and applications that are non-
responsive to the eligibility criteria will not advance through the
review process. We will notify applicants that their application did
not meet submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above. The objective review panel will be composed of HHS/CDC
employees outside of the funding division.
HHS/CDC will provide justification for any decision to fund out of
rank order.
V.3. Anticipated Announcement and Award Dates
Anticipated Award Date: September 15, 2005.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the
HHS/CDC Procurement and Grants Office. The NoA shall be the only
binding, authorizing document between the recipient and HHS. An
authorized Grants Management Officer will sign the NoA and mail it to
the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification by mail of the
results of the application review.
VI.2. Administrative and National Policy Requirements
Successful applicants must comply with the administrative
requirements outlined in 45 CFR Part 74 and Part 92 as appropriate. The
following additional requirements apply to this project:
AR-7 Executive Order 12372
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status
AR-23 States and Faith-Based Organizations
Applicants may find additional information on these requirements on
the HHS/CDC web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
Applicants must include an additional Certifications form from the
PHS5161-1 application in the Grants.gov electronic submission only.
Applicants should refer to http://www.cdc.gov/od/pgo/funding/PHS5161-1-Certificates.pdf.
Once applicants have filled out the form, they should
attach it to the Grants.gov submission as Other Attachments Form.
VI.3. Reporting Requirements
The applicant must provide HHS/CDC with an original, plus two hard
copies of the following reports:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as the application
for continuation, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Measures of Effectiveness, including progress against the
specific numerical targets of the President's Malaria Initiative.
f. Additional Requested Information.
2. Financial status report, no more than 90 days after the end of
the budget period.
3. Final performance reports, no more than 90 days after the end of
the project period.
The grantee must mail these reports to the Grants Management
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
HHS encourages inquiries concerning this announcement.
For general questions, please contact the following office:
Technical Information Management Section, CDC Procurement and Grants
Office, U.S. Department of Health and Human Services, 2920 Brandywine
Road, Atlanta, GA 30341, Telephone: 770-488-2700.
For program technical assistance, please contact the following:
Christi Murray, Project Officer, National Center
[[Page 44656]]
for Infectious Diseases, Centers for Disease Control and Prevention,
U.S. Department of Health and Human Services, 4770 Buford Highway,
Mailstop F-22, Atlanta, GA 300341. Telephone: 770-488-3601. E-mail:
cxm6@cdc.gov.
For financial, grants management, or budget assistance, please
contact the following: Jeff Napier, Grants Management Specialist, CDC
Procurement and Grants Office, U.S. Department of Health and Human
Services, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 770-488-
2614. E-mail: jln1@cdc.gov.
VIII. Other Information
Other HHS funding opportunity announcements can be found on the
HHS/CDC web site, Internet address: http://www.cdc.gov (Click on
``Funding,'' then ``Grants and Cooperative Agreements''), and on the
HHS Office of Global Health Affairs Web site, Internet address: http://www.globalhealth.gov
(Click on ``What's new,'' then ``Funding
Opportunities.'').
Dated: July 28, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention, U.S. Department of Health and Human Services.
[FR Doc. 05-15271 Filed 8-2-05; 8:45 am]
BILLING CODE 4163-18-P